BackNeuroSense Therapeutics Overview

NeuroSense Therapeutics Total Assets

Latest total assets for NRSN: $1M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1.03M
↓ 77.53% YoYΔ $-3.55M vs prior year quarter

Peer average / median

Loading

NeuroSense Therapeutics Total Assets History

Loading

NeuroSense Therapeutics vs. peers: Total Assets Comparison

Loading

NeuroSense Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NeuroSense Therapeutics (NRSN) FAQ

As of the most recent data (December 2025), NRSN shows a total assets of $1M. That compares with $4.6M in the prior-year period — down 77.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRSN's total assets is now $1M (was $4.6M) — a 77.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NeuroSense Therapeutics is outperforming or lagging.

Tracking NRSN's total assets over time shows whether NeuroSense Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $1M That compares with $4.6M in the prior-year period — down 77.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has NeuroSense Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $1M) with ownership activity and broader fundamentals.